What do analysts expect the price target to be for AUGMEDIX INC (AUGX)?
10 analysts have analysed AUGX and the average price target is 3.6 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 2.35.
AUGMEDIX INC (AUGX) Forecast, Price Target & Analyst Ratings
NASDAQ:AUGX • US05105P1075
Current stock price
2.35 USD
0 (0%)
At close:
2.35 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AUGMEDIX INC (AUGX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Nov 4, 2024
- Period
- Q3 / 2024
- EPS Estimate
- -$0.14
- Revenue Estimate
- 13.222M
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.60
Upside
+ 53.00%
From current price of $2.35 to mean target of $3.60, Based on 10 analyst forecasts
Low
$2.37
Median
$2.98
High
$6.20
Price Target Revisions
1 Month
0.00%
3 Months
1.29%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for AUGX. The average price target is 3.6 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 2.35.
The average price target has been revised upward by 1.29% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
AUGX was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AUGX.
In the previous month the buy percentage consensus was at a similar level.
AUGX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-07-22 | Lake Street | Downgrade | Buy -> Hold |
| 2024-05-14 | Lake Street | Maintains | Buy -> Buy |
| 2024-05-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-04-09 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2024-04-03 | B. Riley Securities | Reiterate | Buy |
| 2024-03-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-03-19 | Maxim Group | Maintains | Buy -> Buy |
| 2023-12-15 | Evercore ISI Group | Initiate | In-Line |
| 2023-05-16 | Benchmark | Reiterate | Buy -> Buy |
| 2023-05-15 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-04-21 | Benchmark | Maintains | Buy |
| 2023-04-21 | Maxim Group | Maintains | Buy |
| 2023-04-20 | B. Riley Securities | Reiterate | Buy |
| 2023-03-31 | Benchmark | Reiterate | Buy |
| 2023-03-28 | Maxim Group | Maintains | Buy |
| 2022-03-07 | Lake Street | Initiate | Buy |
| 2022-01-21 | Maxim Group | Initiate | Buy |
| 2021-11-01 | William Blair | Initiate | Outperform |
| 2021-11-01 | Benchmark | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 4, 2024
- Period
- Q3 / 2024
- EPS Estimate
- -$0.14
- Revenue Estimate
- 13.222M
- Revenue Q2Q
- 12.37%
- EPS Q2Q
- -39.40%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-4.06%
EPS (1 Month)
0.00%
EPS (3 Months)
5.74%
Next Earnings Summary
AUGX is expected to report earnings on 11/4/2024. The consensus EPS estimate for the next earnings is -0.14 USD and the consensus revenue estimate is 13.22M USD.
The next earnings revenue estimate has been revised downward by 4.06% in the past 3 months.
Full Analyst Estimates 2024 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.17M 34.53% | 30.93M 39.51% | 44.855M 45.02% | 54.162M 20.75% | 68.554M 26.57% | 63.24M -7.75% | |
| EBITDA YoY % growth | -16.86M -31.51% | -21.51M -27.58% | -17.681M 17.80% | -22.348M -26.40% | -17.986M 19.52% | -12.852M 28.54% | |
| EBIT YoY % growth | -17.55M -28.20% | -22.37M -27.46% | -18.779M 16.05% | -27.365M -45.72% | -22.918M 16.25% | 2.04M 108.90% | |
| Operating Margin | -79.16% | -72.32% | -41.87% | -50.52% | -33.43% | 3.23% | |
| EPS YoY % growth | N/A | N/A -5.15% | -0.45 31.78% | -0.54 -20.13% | -0.48 10.38% | -0.36 26.32% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -39.40% | -0.12 -36.00% | -0.12 -2.00% | -0.10 25.46% | -0.09 37.81% | -0.07 41.67% |
| Revenue Q2Q % growth | 13.222M 12.37% | 17.639M 39.11% | 18.886M 40.20% | 20.3M 48.57% | 21.989M 66.31% | 24.674M 39.88% |
| EBITDA Q2Q % growth | -5.794M -60.49% | -5.131M -57.87% | -4.439M 25.56% | -3.679M 53.25% | -3.132M 45.94% | -2.809M 45.26% |
| EBIT Q2Q % growth | -6.796M -54.45% | -5.91M -35.94% | -5.58M 12.83% | -4.544M 47.92% | -3.774M 44.47% | -3.339M 43.50% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
6.46%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
11.58%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
9.53%
EBIT Next 5 Year
N/A
AUGMEDIX INC / AUGX Forecast FAQ
When does AUGMEDIX INC (AUGX) report earnings?
AUGMEDIX INC (AUGX) will report earnings on 2024-11-04, before the market open.
What are the consensus estimates for AUGMEDIX INC (AUGX) next earnings?
The consensus EPS estimate for the next earnings of AUGMEDIX INC (AUGX) is -0.14 USD and the consensus revenue estimate is 13.22M USD.
What is the consensus rating for AUGMEDIX INC (AUGX) stock?
The consensus rating for AUGMEDIX INC (AUGX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.